Olivier Calvayrac
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 02, 2025
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies.
Journal: Nature communications
Published: March 02, 2024
In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma.
Journal: Cell reports. Medicine
Published: July 03, 2023
Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer.
Journal: Cancers
Published: April 19, 2022
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease.
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease.
Journal: Respiratory medicine and research
Published: March 10, 2022
Vγ9Vδ2 T Cells Activation Through Phosphoantigens Can Be Impaired by a RHOB Rerouting in Lung Cancer.
Journal: Frontiers in immunology
Published: April 01, 2020
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma.
Journal: The Journal of clinical investigation
Published: December 18, 2018
Cytoplasmic p27Kip1 promotes tumorigenesis via suppression of RhoB activity.
Journal: The Journal of pathology
Published: April 10, 2018
The Ras-related GTPase RhoB, a relevant actor in the adaptive resistance to EGFR tyrosine kinase inhibitors in lung cancers
Journal: Medecine sciences : M/S
Published: February 01, 2018
The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.
Journal: EMBO molecular medicine
Published: December 23, 2016
RHOB expression controls the activity of serine/threonine protein phosphatase PP2A to modulate mesenchymal phenotype and invasion in non-small cell lung cancers.
Journal: Small GTPases
Published: September 28, 2016
Molecular biomarkers for lung adenocarcinoma.
Journal: The European respiratory journal
Published: August 31, 2016
Last Updated: 09/26/2026